Toshio Imai

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Monoclonal Antibody

Rheumatoid Arthritis

Recombinant Human

Top Venues

Cancer research communications

Arthritis & rheumatology (Hoboken, N.J.)

ImmunoTargets and therapy

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Jason W-L Eng, Yu Kato, Yusuke Adachi, Bhairavi Swaminathan, L A Naiche, Rahul Vadakath, Yoshimasa Sakamoto, Youya Nakazawa, Sho Tachino, Ken Ito, Takanori Abe, Yukinori Minoshima, Kana Hoshino-Negishi, Hideaki Ogasawara, Tomomi Kawakatsu, Miyuki Nishimura, Masahiko Katayama, Masashi Shimizu, Kazuhiro Tahara, Toshitaka Sato, Katsuhisa Suzuki, Kishan Agarwala, Masao Iwata, Kenichi Nomoto, Yoichi Ozawa, Toshio Imai, Yasuhiro Funahashi, Junji Matsui, Jan K Kitajewski
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium. Cancer research communications 4 (7) (2024)
Jason W-L Eng, Yu Kato, Yusuke Adachi, Bhairavi Swaminathan, L A Naiche, Rahul Vadakath, Yoshimasa Sakamoto, Youya Nakazawa, Sho Tachino, Ken Ito, Takanori Abe, Yukinori Minoshima, Kana Hoshino-Negishi, Hideaki Ogasawara, Tomomi Kawakatsu, Miyuki Nishimura, Masahiko Katayama, Masashi Shimizu, Kazuhiro Tahara, Toshitaka Sato, Katsuhisa Suzuki, Kishan Agarwala, Masao Iwata, Kenichi Nomoto, Yoichi Ozawa, Toshio Imai, Yasuhiro Funahashi, Junji Matsui, Jan K Kitajewski
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium. Cancer research communications 4 (7) (2024)
Jason W-L Eng, Yu Kato, Yusuke Adachi, Bhairavi Swaminathan, L A Naiche, Rahul Vadakath, Yoshimasa Sakamoto, Youya Nakazawa, Sho Tachino, Ken Ito, Takanori Abe, Yukinori Minoshima, Kana Hoshino-Negishi, Hideaki Ogasawara, Tomomi Kawakatsu, Miyuki Nishimura, Masahiko Katayama, Masashi Shimizu, Kazuhiro Tahara, Toshitaka Sato, Katsuhisa Suzuki, Kishan Agarwala, Masao Iwata, Kenichi Nomoto, Yoichi Ozawa, Toshio Imai, Yasuhiro Funahashi, Junji Matsui, Jan K Kitajewski
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium. Cancer research communications 4 (7) (2024)
Jason W-L Eng, Yu Kato, Yusuke Adachi, Bhairavi Swaminathan, L A Naiche, Rahul Vadakath, Yoshimasa Sakamoto, Youya Nakazawa, Sho Tachino, Ken Ito, Takanori Abe, Yukinori Minoshima, Kana Hoshino-Negishi, Hideaki Ogasawara, Tomomi Kawakatsu, Miyuki Nishimura, Masahiko Katayama, Masashi Shimizu, Kazuhiro Tahara, Toshitaka Sato, Katsuhisa Suzuki, Kishan Agarwala, Masao Iwata, Kenichi Nomoto, Yoichi Ozawa, Toshio Imai, Yasuhiro Funahashi, Junji Matsui, Jan K Kitajewski
Inhibition of Notch4 using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium. Cancer research communications (2024)
Shuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata, Youya Nakazawa, Daisuke Ito, Sayo Fukushima, Takayuki Nakagawa, Kenji Ichikawa, Yu Kato, Dai Kakiuchi, Aya Goto, Machiko Itoh-Yagi, Tomoki Aota, Satoshi Inoue, Yoshinobu Yamane, Norio Murai, Hiroshi Azuma, Satoshi Nagao, Ken Sasai, Tsuyoshi Akagi, Toshio Imai, Junji Matsui, Tomohiro Matsushima
ER-001259851-000, a novel selective inhibitor of AXL, overcomes resistance to antimitotic drugs. Molecular cancer therapeutics (2022)
Yoshikazu Kuboi, Yukiko Kuroda, Masayoshi Ohkuro, Sotaro Motoi, Yoshiya Tomimori, Hisataka Yasuda, Nobuyuki Yasuda, Toshio Imai, Koichi Matsuo
The Fractalkine-CX3CR1 Axis Regulates Non-inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival. JBMR plus 6 (10) (2022)
Sotaro Motoi, Mai Uesugi, Takashi Obara, Katsuhiro Moriya, Yoshihisa Arita, Hideaki Ogasawara, Motohiro Soejima, Toshio Imai, Tetsu Kawano
Serum APOA4 Pharmacodynamically Represents Administered Recombinant Human Hepatocyte Growth Factor (E3112). International journal of molecular sciences 22 (9) (2021)
Yoshiya Tanaka, Tsutomu Takeuchi, Hisashi Yamanaka, Toshihiro Nanki, Hisanori Umehara, Nobuyuki Yasuda, Fumitoshi Tago, Yasumi Kitahara, Makoto Kawakubo, Kentaro Torii, Seiichiro Hojo, Tetsu Kawano, Toshio Imai
Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study. Arthritis & rheumatology (Hoboken, N.J.) 73 (4) (2021)
Yoshiya Tanaka, Kana Hoshino-Negishi, Yoshikazu Kuboi, Fumitoshi Tago, Nobuyuki Yasuda, Toshio Imai
Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases. ImmunoTargets and therapy 9 (2020)